HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsPricing
Theme
Help Login Register
Market News Stocks News ETF News Crypto News

CytomX Therapeutics Inc.

Contributing Author

Recent Articles by CytomX Therapeutics Inc.

May-29
CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference CTMX GlobeNewswire
May-19
CytomX Therapeutics Announces First Patient Dosed in Combination Arm of Phase 1 Study of CX-801 plus KEYTRUDA (pembrolizumab) in Patients with Metastatic Melanoma CTMX GlobeNewswire
May-12
CytomX Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock CTMX GlobeNewswire
May-12
CytomX Announces Positive Interim Data From Phase 1 Dose Escalation Study of EpCAM Antibody Drug Conjugate (CX-2051) Candidate in Patients with Advanced Colorectal Cancer (CRC) CTMX GlobeNewswire
May-12
CytomX Therapeutics Announces First Quarter 2025 Financial Results and Provides Business Update CTMX GlobeNewswire
May-05
CytomX Therapeutics to Report First Quarter 2025 Financial Results on May 12, 2025 CTMX GlobeNewswire
Affiliate • Advertise • Theme Settings • Contact • Help • Privacy • Do Not Sell My Data
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 FINVIZ.com. All Rights Reserved.

Upgrade your FINVIZ experience

Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.

Learn more about FINVIZ*Elite